Related Experiment Video
Updated: May 26, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Neuroimaging biomarkers in bipolar disorder
Josselin Houenou1, Marc-Antoine d'Albis, Francois-Eric Vederine
1AP-HP, University Paris-East, Department of Psychiatry, Henri Mondor-Albert Chenevier Hospitals, Creteil, F-94010, France. josselin.houenou@inserm.fr
Objective biomarkers are needed for bipolar disorder (BD) assessment. Neuroimaging reveals cortical-limbic dysregulation in BD, with reduced dorsal brain activity and altered prefrontal-subcortical limbic connectivity, offering potential diagnostic insights.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Bipolar disorder (BD) diagnosis and prognosis require objective biomarkers.
- Neuroimaging techniques offer a promising avenue for identifying such biomarkers.
- Current understanding suggests neurobiological models involving cortical-limbic dysregulation in BD.
Purpose of the Study:
- To review structural and functional neuroimaging studies in bipolar disorder.
- To explore neurobiological models of BD based on neuroimaging findings.
- To identify potential biomarkers for BD assessment.
Main Methods:
- Systematic review of structural and functional neuroimaging studies in bipolar disorder.
- Analysis of diffusion tensor imaging (DTI) for anatomical connectivity.
- Analysis of functional magnetic resonance imaging (fMRI) for functional connectivity.
Main Results:
- Neuroimaging suggests decreased volume and activity in dorsal brain structures in BD.
- Evidence points to reduced inhibition of the ventral-limbic network, enhancing emotional responses.
- Abnormal prefrontal-subcortical limbic connectivity identified via DTI and fMRI.
Conclusions:
- Cortical-limbic dysregulation and altered connectivity are key neurobiological features of BD.
- Neuroimaging biomarkers hold potential for improved diagnosis and prognosis of BD.
- Future research necessitates large, well-characterized patient samples for biomarker validation.
Related Concept Videos
Bipolar Disorder
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Mania and Antimanic Drugs: Overview
